Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer Stage IB (Resectable)”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Testing effectiveness (Phase 2)Study completedNCT02927301
What this trial is testing

Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 181
Testing effectiveness (Phase 2)Looking for participantsNCT04933903
What this trial is testing

BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

Who this might be right for
Non Small Cell Lung Cancer
Brown University 25
Testing effectiveness (Phase 2)Study completedNCT00025389
What this trial is testing

Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Chicago 8
Testing effectiveness (Phase 2)Ended earlyNCT04560686
What this trial is testing

Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung Cancer

Who this might be right for
Resectable Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+8 more
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06682884
What this trial is testing

Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung Cancer

Who this might be right for
Neoadjuvant Non-Small Cell Lung Cancer
Peking University People's Hospital 25
Testing effectiveness (Phase 2)Study completedNCT03366766
What this trial is testing

Nivolumab, Cisplatin, and Pemetrexed Disodium or Gemcitabine Hydrochloride in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery

Who this might be right for
Non-Squamous Non-Small Cell Lung CarcinomaStage I Non-Small Cell Lung CancerStage IA Non-Small Cell Lung Carcinoma+5 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 14
Early research (Phase 1)Ended earlyNCT01886573
What this trial is testing

Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)UnknownNCT06020352
What this trial is testing

The Efficacy and Safety of KN046 Combined With Axitinib

Who this might be right for
NSCLC
Shanghai Pulmonary Hospital, Shanghai, China 20
Early research (Phase 1)UnknownNCT05157542
What this trial is testing

Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC

Who this might be right for
Stage III Non-small Cell Lung Cancer
Juan LI, MD 9
Not applicableLooking for participantsNCT06250829
What this trial is testing

Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IB (Resectable)Non-small Cell Lung Cancer Stage II (Resectable)Non-small Cell Lung Cancer Stage ⅢA (Resectable)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Testing effectiveness (Phase 2)Looking for participantsNCT06532591
What this trial is testing

Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC

Who this might be right for
NSCLC
Sichuan Cancer Hospital and Research Institute 20
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)WithdrawnNCT05400577
What this trial is testing

Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07231575
What this trial is testing

Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC

Who this might be right for
Neoadjuvant ImmunotherapyNSCLCChemo-free Therapy
Sun Yat-sen University 39
Testing effectiveness (Phase 2)Ended earlyNCT00958321
What this trial is testing

Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35

Who this might be right for
Lung CancerMetastatic Cancer
Cancer Trials Ireland 40
Testing effectiveness (Phase 2)Ended earlyNCT00232206
What this trial is testing

Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-small-Cell Lung Carcinoma
Providence Health & Services 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06221462
What this trial is testing

Neoadjuvant Sintilimab Plus Anlotinib Therapy in IB-IIIB Resectable Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Ningbo No.2 Hospital 30
Early research (Phase 1)Ended earlyNCT04348292
What this trial is testing

Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+7 more
Emory University 3
Testing effectiveness (Phase 2)Study completedNCT01443078
What this trial is testing

Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 42
Testing effectiveness (Phase 2)Looking for participantsNCT04302025
What this trial is testing

Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Genentech, Inc. 99
Load More Results